|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Correlation Between Development
of Rash and Efficacy in Patients Treated with the Epidermal Growth
Factor Receptor Tyrosine Kinase Inhibitor Erlotinib in Two Large
Phase III Studies Clin Cancer Res. 2007 Jul 1;13(13):3913-21.
PMID: 17606725 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |